학술논문
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing
Document Type
Article
Author
Appelbaum, J.; Oda, K.; Tampella, G.; Evandy, C.; Sarkar, S.; Leonardi, M.; Logan, R.; Fitzgerald, M.; Tulberg, N.; Rawlings-Rhea, S.; Gardner, R.A.; Lamble, A.; Gustafson, J.A.; Jensen, M.C.; Price, A.E.; Zhang, J.; Leung, W.-H.; Xia, D.; So, P.P.L.; Hilton, S.K.; Martin, U.; Krostag, A.-R.; Zak, D.E.; Lewis, P.; Franke-Welch, S.; Ngwenyama, N.; Gregory, P.D.; Jarjour, J.; Pogson, M.; Astrakhan, A.; Jones, K.; Sanabria, A.; Crago, W.; Timmer, J.; Hollands, A.; Eckelman, B.; Bilic, S.; Woodworth, J.
Source
In: Journal of Clinical Investigation . (Journal of Clinical Investigation, 1 May 2024, 134(9))
Subject
Language
English
ISSN
15588238
00219738
00219738